North America Ophthalmology Market
市场规模（十亿美元）
CAGR :
% 
USD
31.77 Billion
USD
52.37 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 31.77 Billion |
 Market Size (Forecast Year) |
USD 52.37 Billion |
 CAGR |
% |
| Major Markets Players |
北美眼科市場細分，按產品（設備、藥物和其他）、疾病（白內障、屈光不正、青光眼、老年性黃斑變性、炎症性疾病和其他）、綜合眼科檢查（屈光、視力測試、眼壓、前段和瞳孔檢查、視野測試、色覺測試和其他）、最終用戶（診所、醫院、家庭醫療保健和其他分銷渠道（20 年）
北美眼科市場分析
北美眼科市場幾個世紀以來發生了顯著的變化，始於埃及和希臘的古代眼科治療。隨著更先進的手術技術和工具的發展，該領域在 17 和 18 世紀開始形成。 19 世紀，檢眼鏡等創新徹底改變了診斷能力。 20 世紀出現了白內障手術和人工水晶體的發明等突破，以及 20 世紀 90 年代 LASIK 手術的出現。 21 世紀，人口老化、技術進步以及光學相干斷層掃描 (OCT) 和視網膜成像系統等專用診斷和手術設備的發展推動了該行業持續成長。最近的趨勢集中在人工智慧、遠距醫療和生物療法（如基因療法和幹細胞療法）的日益普及，進一步影響市場的成長。如今，由於眼疾盛行率的上升、新技術的出現以及治療方案的不斷改進，眼科市場不斷擴大。
北美洲眼科市場規模
北美眼科市場預計將從 2024 年的 317.7 億美元增至 2032 年的 523.7 億美元，在 2025 年至 2032 年的預測期內以 6.5% 的複合年增長率增長。
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。
北美眼科市場趨勢
“遠距醫療和人工智慧診斷工具的日益普及”
北美眼科市場越來越多地採用遠距醫療和人工智慧診斷工具。這些創新透過實現遠距諮詢和篩檢改變了眼科護理的提供方式，提高了眼科護理的可及性，特別是在服務不足和農村地區。包括機器學習演算法在內的人工智慧技術正被用於分析視網膜影像，檢測糖尿病視網膜病變、青光眼和黃斑部病變等疾病的早期跡象，並提供更快、更準確的診斷。遠距醫療平台使患者能夠與眼科醫生聯繫進行後續諮詢，減少了親自就診的需要，使眼部護理更加方便和高效。這一趨勢不僅改善了患者獲得及時治療的機會，而且提高了醫療保健系統的整體效率，使其成為眼科領域市場成長的主要驅動力。因此，這些技術的整合預計將繼續擴大，特別是在醫療保健基礎設施仍在發展的新興市場。
報告範圍和北美眼科市場細分
|
屬性 |
北美眼科市場洞察 |
|
涵蓋的領域 |
按 產品：設備、藥品和其他 依 疾病：白內障、屈光不正、青光眼、老年性黃斑部病變、發炎性疾病等 全面 眼科 檢查：屈光檢查、視力檢查、眼壓檢查、眼前節及瞳孔檢查、視野檢查、色覺檢查等 依最終用戶分類：診所、醫院、家庭醫療保健等 按分銷 管道：零售、直接投標及其他 |
|
覆蓋區域 |
美國、加拿大和墨西哥 |
|
主要市場參與者 |
愛爾康（瑞士）、博士倫（加拿大）、卡爾蔡司醫療（德國）、豪雅株式會社（日本）、強生服務公司（美國）、依視路國際（法國）、拓普康株式會社（日本）、Glaukos 株式會社（美國）、Haag-Streit 集團（瑞士）、加州尼德克株式會社（瑞士尼德克）（瑞士尼德克）（瑞士）株（瑞士）株） Ag（瑞士）、庫柏公司（美國）、Lumenis Be Ltd.（以色列）、Reichert Inc.（紐約）、拜耳股份公司（德國）、諾華股份公司（瑞士）、艾伯維公司（美國）、F. Hoffmann-La Roche Ltd.（瑞士）、東洋製藥（義大利）、參天株式會社（日本製藥）等。 |
|
市場機會 |
|
|
加值資料資訊集 |
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。 |
北美眼科市場定義
眼科學是醫學和外科的一個分支，專注於眼部疾病的診斷、治療和預防。它包括對影響眼睛和視覺系統的疾病（例如白內障、青光眼、黃斑部病變和糖尿病視網膜病變）的醫療和外科治療。
北美眼科市場定義動態
驅動程式
- 眼部疾病盛行率不斷上升
白內障、黃斑部病變和糖尿病視網膜病變等眼部疾病的盛行率不斷上升，是北美眼科市場的重要驅動力。隨著北美人口老化，這些疾病的發生率正在上升。白內障會導致視力模糊和失明，因此需要擴大手術和矯正治療市場。同樣，黃斑部病變和糖尿病視網膜病變也需要先進的診斷工具和專門的治療方法。受影響人數的不斷增加確保了對眼部保健服務（包括手術、藥物和創新診斷技術）的持續需求。由於醫療保健提供者和製造商努力滿足對有效治療和解決方案日益增長的需求，眼部疾病的激增直接推動了市場擴張。
例如，
- 2022年7月，根據NCBI發表的文章，失明的盛行率隨著年齡的增長而上升，從50-59歲族群的0.45%上升到80歲及以上族群的11.62%。女性（2.31%）和農村居民（2.14%）的比例較高。 26.68% 的參與者也受到視力障礙的影響，呈現類似的趨勢。眼部疾病負擔日益加重，尤其是老年人，這推動了對眼科治療和技術的需求，從而促進了眼科市場的發展
- 2023年8月，根據世界衛生組織在北美發表的文章，全球超過22億人患有視力障礙，其中近10億例是可以預防或無法治療的。視力問題的日益普遍凸顯了對眼部保健服務、治療和矯正解決方案的需求日益增長。隨著越來越多的人因可預防或無法解決的疾病尋求醫療救治，眼部疾病負擔的增加成為眼科市場的重要驅動力
與年齡相關的眼部疾病（如白內障、黃斑部病變和糖尿病視網膜病變）的盛行率不斷上升，推動了北美眼科市場的發展。隨著人口老化，這些疾病變得越來越普遍，對治療、手術和診斷工具的需求也隨之增加。隨著越來越多的人需要護理，對先進技術和療法的需求也隨之增長。由於醫療保健提供者和製造商致力於滿足對有效解決方案日益增長的需求，因此眼部疾病的激增推動了市場的成長。
- 重視預防性眼部護理
人們越來越重視預防性眼部護理和視力相關問題的早期發現，這對推動北美眼科市場的發展發揮著重要作用。隨著人們對眼睛健康重要性的認識不斷提高，越來越多的人開始進行常規眼科檢查，以便早期發現青光眼、糖尿病視網膜病變和白內障等疾病。早期診斷可以及時幹預，降低視力喪失的風險並改善整體眼睛健康。這種積極主動的方法不僅改善了患者的治療效果，而且還刺激了對眼科服務、診斷工具和矯正治療的需求。人們對預防性護理的日益關注導致對眼保健技術、眼科設備和服務的投資激增，從而促進了市場的擴張。這一趨勢有力地推動了眼科領域的成長。
例如，
- 2022年10月，根據美國國家眼科研究所發表的文章，國家眼科健康教育計畫（NEHEP）與衛生專業人員合作，提高人們對早期發現、治療眼部疾病以及視力復健益處的認識。它也針對患有眼疾和視力喪失的高風險族群。這種對預防性護理的關注鼓勵人們及時進行眼科檢查和治療，推動了對眼科服務、診斷工具和產品的需求，從而推動了眼科市場的發展
- 2024年10月，根據衛生服務總局發表的文章，國家失明和視力障礙控制計劃（NPCB&VI）旨在透過在所有醫療層面識別和治療可治癒的失明來降低失明盛行率。透過專注於早期發現和解決可避免的失明，該計劃強調了預防性護理的重要性。這項舉措推動了對眼部保健服務、診斷工具和治療的需求，為北美眼科市場的成長做出了重大貢獻
人們對預防性眼部保健和早期發現的日益關注極大地推動了北美眼科市場的發展。隨著人們對眼睛健康認識的提高，越來越多的人選擇進行常規眼科檢查，以便及早發現青光眼和白內障等疾病。早期發現可以進行有效治療，防止視力進一步喪失。這種積極主動的方法正在推動對診斷工具、眼科服務和矯正治療的需求。預防性護理日益重要，促使人們投資先進的眼部保健技術，從而促進眼科市場的整體成長並確保其持續擴張。
機會
- 人口老化加劇
老齡人口的成長為北美眼科市場帶來了重大機遇，因為老年人更容易患上各種眼部疾病。白內障、老年黃斑部病變 (AMD)、糖尿病視網膜病變和青光眼等疾病在老年人中很普遍，對眼科護理和治療的需求很大。因此，醫療保健系統和眼科服務提供者準備擴大其服務範圍，增強診斷和治療選擇，並滿足這一人群的獨特需求。不斷增長的患者群體需要一系列解決方案，從手術介入和先進的藥物治療到視力矯正產品，確保對眼科手術和產品的需求穩定成長。
例如，
- 2023年3月，根據美國國家醫學圖書館發表的一篇文章，白內障是老年人視力障礙的主要原因。眾所周知，水晶體混濁與多種老年疾病有關，包括虛弱、跌倒風險、憂鬱和認知障礙。此外，根據相同來源的數據，2020 年，全球 50 歲及以上患者失明的主要原因是白內障，其次是青光眼、矯正不足的屈光不正、老年黃斑部病變和糖尿病視網膜病變
- 2022 年 8 月，根據美國眼科學會發表的一篇文章，AMD 是一種常見的眼部疾病，通常見於 50 歲以上的成年人。此外，有報導稱，75 歲以上的美國人中，有一半患有白內障
此外，滿足老齡人口的眼睛健康需求可以刺激眼科領域進一步的研發投資。製藥公司和醫療器材製造商專注於創造專門針對與年齡相關的疾病的創新解決方案，這可能會帶來治療方案和患者護理方面的突破。遠距眼科和先進影像技術等新技術的融合，有助於更好地管理老年人的眼睛健康，使遠端監測和治療變得更加容易。總體而言，人口老化增加了對現有眼科服務的需求，並為北美眼科市場的創新和成長提供了肥沃的土壤。
- 線上零售和電子健康平台的興起
線上零售和電子健康平台的興起為北美眼科市場提供了重大機遇，讓消費者更容易獲得各種眼部護理產品和服務。隨著電子商務的日益普及，患者可以在家中舒適地購買處方眼鏡、隱形眼鏡和非處方眼部護理產品等物品。這一趨勢對於年輕、精通科技的消費者以及那些難以接觸傳統眼鏡店的偏遠地區的消費者尤其有吸引力。能夠在線上比較價格、閱讀評論和訪問更廣泛的產品可以提高客戶滿意度並鼓勵使用，從而推動眼科產品領域的成長。
例如，
- 2023年9月，根據《印度時報》報道，「紅眼症」疫情導致眼科藥品銷售激增。 8 月銷售額連續第二個月年增近 30%，增幅幾乎是整體市場的五倍。這一增長反映了過去幾個月全國範圍內結膜炎和眼部併發症的大量發生
- 2020 年 4 月，一篇題為《患者對網上購買眼鏡的看法》的文章指出，網上購買隱形眼鏡的現象正在興起：澳大利亞、美國和英國 10%–20% 的隱形眼鏡佩戴者已經考慮或研究過網上購買的可能性
除了零售機會外，電子健康平台還提供遠距醫療服務，讓患者可以遠距諮詢眼科護理專業人員。透過常規眼科檢查、追蹤和更嚴重疾病的分類進行虛擬諮詢可以顯著改善獲得護理的機會，特別是對於老年人或行動不便的人。這些平台增強了患者的參與度和對眼部健康建議的遵守，並允許眼科醫生不受地理邊界的限制，接觸更廣泛的患者群體。此外，數位健康工具的整合，例如用於監測眼睛健康或管理慢性病的行動應用程序，可以創造無縫的患者體驗並促進主動的眼睛護理，進一步推動眼科市場的成長。
限制/挑戰
- 眼科手術的副作用和併發症
儘管眼科治療取得了重大進步，但某些眼科手術，尤其是外科手術，仍存在感染、疤痕或視力障礙等副作用和併發症的風險。這些潛在風險可能會阻止患者接受特定治療，尤其是涉及侵入性手術的治療。對視力下降或恢復時間延長等不良後果的恐懼可能導致人們不願意尋求治療，從而限制了某些療法的整體採用。此外，手術引起的併發症可能需要額外的治療，從而進一步增加醫療成本並影響患者對先進治療的信任。由於擔心可能產生的負面副作用而不願接受治療，減緩了新技術和新療法的採用，限制了眼科市場的整體成長。
例如，
- 2024年10月，根據《哈佛健康》發表的文章，現代眼科手術雖然能有效治療白內障和青光眼等疾病，但往往會導致乾眼症等併發症，其特徵是灼熱、沙礫或發癢的感覺。這種副作用可能會讓患者感到不舒服和沮喪，導致一些人猶豫或避免進行眼科手術。因此，治療併發症成為眼科市場成長的限制因素
- 2021 年 7 月，根據《今日醫學新聞》發表的文章，在接受雷射眼科手術的人中，高達 95% 的人可能會出現眼睛乾澀，而 20% 的人報告出現眩光或光暈等視覺障礙。此外，每 50 人中就有 1 人可能患有視力模糊或「撒哈拉沙漠」症候群。這些副作用可能會阻止患者選擇手術，限制雷射手術的採用，並抑制眼科市場的成長
儘管眼科技術取得了進步，但一些手術治療仍存在感染、疤痕或視力障礙等風險。這些併發症可能會使患者不願意選擇某些療法，尤其是侵入性手術。對不良後果和額外治療費用的擔憂可能會阻礙患者尋求治療的意願，從而減緩新療法的採用。這種不情願限制了北美眼科市場的成長。
- 農村地區獲得專業眼科護理的機會有限
儘管醫療基礎設施取得了進步，但在農村和偏遠地區獲得專業眼科護理的機會仍然有限，這嚴重阻礙了這些地區眼科市場的成長潛力。許多農村人口仍然面臨缺乏訓練有素的眼科護理專業人員、設施不足以及獲得先進診斷和治療技術的機會有限等挑戰。因此，這些地區的人們往往難以及時得到眼部疾病的診斷和治療，導致可預防失明和視力障礙的發生率更高。專科護理的有限性限制了市場擴張，減少了對先進眼部保健服務和產品的採用。這種准入障礙持續成為北美眼科市場整體成長的主要限制因素。
例如，
- 2023年2月，根據NCBI發表的文章，印度龐大的農村人口面臨著巨大的未滿足的眼部保健需求，大多數設施和專業人員集中在城市和半城市地區。城鄉之間獲得眼科護理的差距仍然是一個挑戰，限制了治療的可及性。醫療資源分配不均阻礙了農村地區廣泛獲得基本醫療服務，從而限制了北美眼科市場的成長
- 2024年3月，根據Research Gate發表的文章，即使在成功舉辦眼科營之後，偏遠地區仍缺乏連結性和訓練有素的工作人員，這阻礙了人們獲得持續的眼科護理。由於缺乏適當的基礎設施，這些地區的患者難以接受後續護理或高級治療。醫療保健服務方面的這種差距限制了眼保健計劃的覆蓋範圍和有效性，從而限制了北美眼科市場的成長
儘管醫療保健有所改善，但在農村地區獲得專業眼科護理的機會仍然有限。眼科護理專業人員、先進技術和設施的短缺阻礙了及時治療和診斷，導致可避免失明的發生率較高。這種有限的准入限制了這些地區採用先進的治療和服務，從而阻礙了北美眼科市場的成長。
北美眼科市場範圍
市場根據產品、疾病、全面眼科檢查、最終用戶和分銷管道進行細分。這些細分市場之間的成長將幫助您分析行業中成長微弱的細分市場，並為用戶提供有價值的市場概覽和市場洞察，幫助他們做出策略決策，確定核心市場應用。
按產品
- 裝置
- 手術器械
- 白內障手術器械
- 眼科黏彈裝置
- 超音波乳化裝置
- 白內障手術雷射
- 人工水晶體注射器
- 玻璃體視網膜手術器械
- 玻璃體切除機
- 玻璃體視網膜包
- 光凝雷射
- 玻璃體切除術探頭
- 照明設備
- 屈光手術設備
- 飛秒雷射
- 準分子雷射
- 其他屈光手術雷射器
- 青光眼手術器械
- 青光眼引流裝置
- 微創青光眼手術設備
- 青光眼雷射系統
- 診斷設備
- 光學相干斷層掃描 (OCT) 掃描儀
- 自動驗光儀和角膜曲率計
- 眼壓計
- 綜合驗光儀
- 視網膜鏡
- 檢眼鏡
- 裂隙燈
- 視野計/視野分析儀
- 角膜地形圖系統
- 眼底照相機
- 眼科超音波成像系統
- A掃描成像系統
- B掃描成像系統
- 角膜厚度計
- 超音波生物顯微鏡
- 焦度計
- 波前像差儀
- 光學生物測量系統
- 鏡面顯微鏡
- 圖表投影儀
- 眼科手術配件
- 手術器械和套件
- 眼科鉗
- 眼科刮刀
- 眼科尖端和手柄
- 眼科套管
- 眼科剪刀
- 其他手術配件
- 眼科顯微鏡
- 手術器械
- 藥品及副產品
- 抗VEGF藥物
- 雷珠單抗
- 貝伐單抗
- 視網膜疾病藥物
- 抗青光眼藥物
- 前列腺素類似物
- 拉坦前列素
- 比馬前列素
- 曲伏前列素
- 他氟前列素
- 拉坦前列素
- β腎上腺素拮抗劑
- 馬來酸噻嗎拉
- 倍他洛爾
- α腎上腺素激動劑
- 腎上腺素
- 地哌普林
- 縮瞳劑
- 毛果芸香鹼
- 對於他的工作
- 前列腺素類似物
- 乾眼症藥物
- 抗發炎藥物
- 類固醇抗發炎藥
- 非類固醇抗發炎藥
- 過敏性結膜炎藥物
- 其他的
- 抗VEGF藥物
- 毒品（按類型）
- 品牌
- 通用的
- 處方藥
- 處方
- 在櫃檯
- 藥物，依給藥途徑
- 外用
- 眼藥水
- 眼部護理液
- 乳膏和藥膏
- 凝膠
- 其他的
- 局部眼科
- 玻璃體內
- 結膜下
- 球後
- 前房內
- 注射劑
- 肌肉注射
- 靜脈
- 其他的
- 口服
- 藥片
- 膠囊
- 其他的
- 其他的
- 外用
- 其他的
- 視力保健產品
- 眼鏡
- 隱形眼鏡
- 軟性隱形眼鏡
- 混合型隱形眼鏡
- 硬式透氣性隱形眼鏡
- 其他的
- 視力保健產品
按疾病
- 白內障
- 屈光不正
- 青光眼
- 老年性黃斑部病變
- 發炎性疾病
- 其他的
透過全面的眼科檢查
- 折射
- 自動折射儀
- 一套試鏡鏡片
- 睫狀肌麻痺藥物
- 試用框架
- 自發光/鏡面視網膜鏡
- 傑克森十字圓柱體
- 視力測試
- 斯內倫視力表
- 近距離視力表
- 眼壓
- 眼壓計（Goldmann、Tono-Pen、Perkins、Shiotz）
- 其他的
- 眼前節和瞳孔檢查
- 裂隙燈生物顯微鏡
- 火炬之光
- 視野檢查
- Central 30-2 全閾值 Humphrey 視野分析儀
- 倍頻週長
- 戈德曼運動週長儀
- 色覺測試
- 其他的
按最終用戶
- 診所
- 醫院
- 家庭醫療保健
- 其他的
按分銷管道
- 零售
- 零售店
- 醫院藥房
- 網路藥局
- 直接投標
- 其他的
北美眼科市場區域分析
市場根據產品、疾病、全面眼科檢查、最終用戶和分銷管道進行細分。
該市場涵蓋的國家包括美國、加拿大和墨西哥。
由於先進的醫療基礎設施、高昂的醫療支出以及人口老化和眼疾盛行率不斷上升，美國預計將佔據市場主導地位。此外，對研究、開發和採用尖端技術的大量投資推動了該地區的市場領先地位。
報告的國家部分還提供了影響個別市場因素以及影響市場當前和未來趨勢的國內市場監管變化。下游和上游價值鏈分析、技術趨勢和波特五力分析、案例研究等數據點是用於預測各國市場情景的一些指標。此外，在對國家數據進行預測分析時，還考慮了北美品牌的存在和可用性以及由於來自本地和國內品牌的大量或稀缺的競爭而面臨的挑戰、國內關稅和貿易路線的影響。
北美眼科市場份額
市場競爭格局提供了競爭對手的詳細資訊。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投資、新市場計劃、北美業務、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度、應用優勢。以上提供的數據點僅與公司對市場的關注有關。
北美眼科市場領導者有：
- 愛爾康（瑞士）
- 博士倫（加拿大）
- 卡爾蔡司醫療（德國）
- 豪雅株式會社（日本）
- 強生服務公司（美國）
- 依視路國際（法國）
- 日本拓普康株式會社
- Glaukos公司（美國）
- Haag-Streit集團（瑞士）
- 尼德克有限公司（美國）
- Staar Surgical（加州）
- Ziemer Ophthalmic Systems Ag（瑞士）
- 庫柏公司（美國）
- Lumenis Be Ltd.（以色列）
- Reichert Inc.（紐約）
- 拜耳股份公司（德國）
- 諾華公司（瑞士）
- Abbvie Inc.（美國）
- F. Hoffmann-La Roche Ltd.（瑞士）
- Dompé（義大利）
- 參天製藥株式會社（日本）
北美眼科市場最新發展
- 2024年10月，在AAO 2024會議上，愛爾康展示了其創新成果，包括用於治療青光眼的Voyager DSLT、UNIFEYE和UNIPEXY手持式氣體輸送系統，以及乾眼症治療藥物AR-15512的關鍵數據。這些進步旨在改善手術結果和手術效率
- 2024 年 9 月，EssilorLuxottica 與 Meta 延長合作夥伴關係，達成長期協議，共同開發多代智慧眼鏡產品。基於雷朋 Meta 眼鏡的成功，兩家公司旨在共同塑造穿戴式科技的未來
- 2024 年 10 月，博士倫在芝加哥舉行的 2024 年 AAO 會議上展示了新的科學數據和教育活動。重點包括關於 enVista Envy IOL、TENEO 準分子雷射、VYZULTA 的研究，以及關於 Blink Nutritears、MIEBO 和 Xiidra 的演示
- 2024 年 4 月，AbbVie 完成對 Cerevel Therapeutics 的收購，增強了其神經科學產品組合。此次收購包括 Cerevel 前景看好的臨床階段資產，例如用於治療精神分裂症的 Emraclidine 和用於治療帕金森氏症的 Tavapadon，從而加強了 AbbVie 在神經病學和精神病學領域的地位
- 2023 年 9 月，諾華公司完成了將其「眼科前線」資產以高達 25 億美元的價格出售給博士倫公司的交易，其中包括 17.5 億美元的預付現金和潛在的里程碑付款。該交易包括 Xiidra、SAF312、AcuStream 和 OJL332。諾華推進其策略，重點關注未來成長的優先治療領域
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA OPHTHALMOLOGY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 NORTH AMERICA OPHTHALMOLOGY MARKET : REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF EYE DISEASES
6.1.2 FOCUS ON PREVENTATIVE EYE CARE
6.1.3 GOVERNMENT EYECARE INITIATIVES
6.1.4 INNOVATIONS IN OPHTHALMIC SURGICAL TECHNIQUES
6.2 RESTRAINTS
6.2.1 SIDE EFFECTS AND COMPLICATIONS RELATED TO EYE SURGERIES
6.2.2 LIMITED ACCESS TO SPECIALIZED OPHTHALMIC CARE IN RURAL AREAS
6.3 OPPORTUNITIES
6.3.1 RISE IN THE AGING POPULATION
6.3.2 RISE IN ONLINE RETAIL AND E-HEALTH PLATFORMS
6.3.3 ENHANCED PATIENT EDUCATION
6.4 CHALLENGES
6.4.1 RISING COSTS OF OPHTHALMIC TREATMENTS
6.4.2 SHORTAGE OF EYE CARE PROFESSIONALS
7 NORTH AMERICA OPHTHALMOLOGY MARKETNORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS
7.1 OVERVIEW
7.2 DEVICE
7.2.1 SURGICAL DEVICE
7.2.1.1 CATARACT SURGICAL DEVICES
7.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES
7.2.1.2.1 PHACOEMULSIFICATION DEVICES
7.2.1.2.2 CATARACT SURGICAL LASERS
7.2.1.2.3 IOL INJECTORS
7.2.1.3 VITREORETINAL SURGICAL DEVICES
7.2.1.3.1 VITREORETINAL PACKS
7.2.1.3.2 VITRECTOMY MACHINES
7.2.1.3.3 VITRECTOMY PROBES
7.2.1.3.4 PHOTOCOAGULATION LASERS
7.2.1.3.5 ILLUMINATION DEVICES
7.2.1.4 REFRACTIVE SURGICAL DEVICES
7.2.1.4.1 FEMTOSECOND LASERS
7.2.1.4.2 EXCIMER LASERS
7.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS
7.2.1.5 GLAUCOMA SURGICAL DEVICES
7.2.1.5.1 GLAUCOMA DRAINAGE DEVICES
7.2.1.5.2 GLAUCOMA LASER SYSTEMS
7.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES
7.2.2 DIAGNOSTIC DEVICE
7.2.2.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS
7.2.2.2 AUTOREFRACTORS & KERATOMETERS
7.2.2.3 TONOMETERS
7.2.2.4 PHOROPTERS
7.2.2.5 RETINOSCOPES
7.2.2.6 OPHTHALMOSCOPES
7.2.2.7 SLIT LAMPS
7.2.2.8 PERIMETERS/VISUAL FIELD ANALYZERS
7.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS
7.2.2.10 FUNDUS CAMERAS
7.2.2.11 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
7.2.2.11.1 A- SCAN IMAGING SYSTEM
7.2.2.11.2 B-SCAN IMAGING SYSTEM
7.2.2.11.3 PACHYMETERS
7.2.2.11.4 ULTRASOUND BIOMICROSCOPES
7.2.2.12 LENSMETERS
7.2.2.13 WAVEFRONT ABERROMETERS
7.2.2.14 OPTICAL BIOMETRY SYSTEMS
7.2.2.15 SPECULAR MICROSCOPES
7.2.2.16 CHART PROJECTORS
7.2.3 OPHTHALMIC SURGICAL ACCESSORIES
7.2.3.1 SURGICAL INSTRUMENTS & KITS
7.2.3.2 OPHTHALMIC FORCEPS
7.2.3.3 OPHTHALMIC SPATULA
7.2.3.4 OPHTHALMIC TIPS AND HANDLES
7.2.3.5 OPHTHALMIC CANNULAS
7.2.3.6 OPHTHALMIC SCISSORS
7.2.3.7 OTHERS SURGICAL ACCESSORIES
7.2.4 OPHTHALMIC MICROSCOPES
7.3 DRUGS
7.3.1 ANTI-VEGF DRUGS
7.3.1.1 RANIBIZUMAB
7.3.1.2 BEVACIZUMAB
7.3.2 ANTI-GLAUCOMA DRUGS
7.3.2.1 PROSTAGLANDIN ANALOGS
7.3.2.1.1 LATANOPROST
7.3.2.1.2 BIMATOPROST
7.3.2.1.3 TRAVOPROST
7.3.2.1.4 TAFLUPROST
7.3.2.1.5 LATANOPROSTENE
7.3.2.2 BETA ADRENERGIC ANTAGONISTS
7.3.2.2.1 TIMOLAL MALEATE
7.3.2.2.2 BETAXOLOL
7.3.2.3 ALPHA ADRENERGIC AGONISTS
7.3.2.3.1 EPINEPHRINE
7.3.2.3.2 DEPIVEPRINE
7.3.2.4 MIOTICS
7.3.2.4.1 PILOCARPINE
7.3.2.4.2 ESERINE
7.3.3 ANTI-INFLAMMATION DRUGS
7.3.3.1 STEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.4 RETINAL DISORDER DRUGS
7.3.5 DRY EYE DRUGS
7.3.6 ALLERGIC CONJUCTIVITIS DRUGS
7.3.7 OTHERS
7.3.7.1 BRANDED
7.3.7.2 GENERIC
7.3.7.3 PRESCRIPTION
7.3.7.4 OVER THE COUNTER
7.3.7.5 TOPICAL
7.3.7.6 LOCAL OCULAR
7.3.7.7 INJECTABLES
7.3.7.8 ORAL
7.3.7.9 OTHERS
7.3.7.10 EYE DROPS
7.3.7.11 EYE SOLUTION
7.3.7.12 CREAM & OINTMENTS
7.3.7.13 GEL
7.3.7.14 OTHERS
7.3.7.15 INTRAVITREAL
7.3.7.16 SUBCONJUNCTIVAL
7.3.7.17 RETROBULBAR
7.3.7.18 INTRACAMERAL
7.3.7.19 INTRAMUSCULAR
7.3.7.20 INTRAVENOUS
7.3.7.21 OTHERS
7.3.7.22 TABLET
7.3.7.23 CAPSULES
7.3.7.24 OTHERS
7.4 OTHERS
7.4.1 VISION CARE PRODUCTS
7.4.1.1 SPECTACLES
7.4.1.2 CONTACT LENSES
7.4.1.2.1 SOFT CONTACT LENSES
7.4.1.2.2 HYBRID CONTACT LENSES
7.4.1.2.3 RIGID GAS PERMEABLE LENSES
7.4.2 OTHERS
8 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES
8.1 OVERVIEW
8.2 CATARACT
8.3 REFRACTIVE DISORDERS
8.4 GLAUCOMA
8.5 AGE-RELATED MACULAR DEGENERATION
8.6 INFLAMMATORY DISEASES
8.7 OTHERS
9 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION
9.1 OVERVIEW
9.2 REFRACTION
9.2.1 AUTOMATED REFRACTOMETERS
9.2.2 SET OF TRIAL LENSES
9.2.3 CYCLOPLEGIC DRUGS
9.2.4 TRIAL FRAME
9.2.5 SELF-ILLUMINATED/ MIRROR RETINOSCOPE
9.2.6 JACKSON CROSS CYLINDER
9.3 VISUAL ACUITY TEST
9.3.1 SNELLEN'S CHART
9.3.2 NEAR VISION CHARTS
9.4 INTRAOCULAR PRESSURE
9.4.1 TONOMETERS (GOLDMANN, TONO-PEN, PERKINS, SHIOTZ)
9.4.2 OTHERS
9.5 ANTERIOR SEGMENT AND PUPILLARY EXAMINATION
9.5.1 SLIT LAMP BIOMICROSCOPE
9.5.2 TORCH LIGHT
9.6 VISUAL FIELDS TEST
9.6.1 CENTRAL 30-2 FULL THRESHOLD HUMPHREY VISUAL FIELD ANALYZER
9.6.2 FREQUENCY DOUBLING PERIMETER
9.6.3 GOLDMANN KINETIC PERIMETER
9.7 COLOR VISION TEST
9.8 OTHERS
10 NORTH AMERICA OPHTHALMOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 CLINICS
10.3 HOSPITALS
10.4 HOME HEALTHCARE
10.5 OTHERS
11 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 RETAIL SALES
11.2.1 RETAIL SHOPS
11.2.2 HOSPITAL PHARMACY
11.2.3 ONLINE PHARMACY
11.3 DIRECT TENDER
11.4 OTHERS
12 NORTH AMERICA OPHTHALMOLOGY MARKET BY GEOGRAPHY
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ALCON
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 JOHNSON & JOHNSON SERVICES, INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ESSILOR LUXOTTICA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 NOVARTIS AG
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 BAUSCH + LOMB
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 REVENUE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ABBVIE INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BAYER AG
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 CARL ZEISS MEDITEC AG
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 COOPER COMPANIES
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.1 DOMPÉ
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 F. HOFFMANN-LA ROCHE LTD
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 GLAUKOS CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 HAAG-STREIT
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 HOYA CORPORATION
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 LUMENIS BE LTD.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 NIDEK CO.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 REICHERT, INC
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 SANTEN PHARMACEUTICAL CO.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 STAAR SURGICAL
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
15.2 TOPCON CORPORATION
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENT
15.21 ZIEMER OPHTHALMIC SYSTEMS AG
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 2 NORTH AMERICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 3 NORTH AMERICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 4 NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 5 NORTH AMERICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 6 NORTH AMERICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 7 NORTH AMERICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 8 NORTH AMERICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 9 NORTH AMERICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 10 NORTH AMERICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 11 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 12 NORTH AMERICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 13 NORTH AMERICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 14 NORTH AMERICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 15 NORTH AMERICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 16 NORTH AMERICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 17 NORTH AMERICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 18 NORTH AMERICA ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 19 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 20 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 21 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 22 NORTH AMERICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 23 NORTH AMERICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 24 NORTH AMERICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 25 NORTH AMERICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 26 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 27 NORTH AMERICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 28 NORTH AMERICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 29 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 30 NORTH AMERICA CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 31 NORTH AMERICA REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 32 NORTH AMERICA GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 33 NORTH AMERICA AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 34 NORTH AMERICA INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 35 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 36 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 37 NORTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 38 NORTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 39 NORTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 40 NORTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 41 NORTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 42 NORTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 43 NORTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 44 NORTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 45 NORTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 46 NORTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 47 NORTH AMERICA COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 48 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 49 NORTH AMERICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 50 NORTH AMERICA CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 51 NORTH AMERICA HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 52 NORTH AMERICA HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 53 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 54 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 55 NORTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 56 NORTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57 NORTH AMERICA DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 58 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 59 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60 NORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 61 NORTH AMERICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 62 NORTH AMERICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 63 NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 64 NORTH AMERICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 65 NORTH AMERICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 66 NORTH AMERICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 67 NORTH AMERICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 68 NORTH AMERICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 69 NORTH AMERICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 70 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 71 NORTH AMERICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 72 NORTH AMERICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 73 NORTH AMERICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 74 NORTH AMERICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 75 NORTH AMERICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 76 NORTH AMERICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 77 NORTH AMERICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 78 NORTH AMERICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 79 NORTH AMERICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 80 NORTH AMERICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 81 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 82 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 83 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 84 NORTH AMERICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85 NORTH AMERICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 86 NORTH AMERICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 87 NORTH AMERICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 88 NORTH AMERICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 89 NORTH AMERICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 90 NORTH AMERICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 91 NORTH AMERICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 92 NORTH AMERICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 93 NORTH AMERICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 94 NORTH AMERICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 95 NORTH AMERICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 96 NORTH AMERICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97 NORTH AMERICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98 U.S. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 99 U.S. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 100 U.S. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 101 U.S. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 102 U.S. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 103 U.S. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 104 U.S. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 105 U.S. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 106 U.S. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 107 U.S. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 108 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 109 U.S. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 110 U.S. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 111 U.S. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 112 U.S. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 113 U.S. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 114 U.S. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 115 U.S. ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 116 U.S. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 117 U.S. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 118 U.S. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 119 U.S. OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 120 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 121 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 122 U.S. DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 123 U.S. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124 U.S. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 125 U.S. INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 126 U.S. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127 U.S. OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 128 U.S. REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 129 U.S. VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 130 U.S. INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 131 U.S. ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 132 U.S. VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 133 U.S. OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 134 U.S. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135 U.S. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136 CANADA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 137 CANADA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 138 CANADA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 139 CANADA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 140 CANADA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 141 CANADA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 142 CANADA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 143 CANADA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 144 CANADA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 145 CANADA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 146 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 147 CANADA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 148 CANADA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 149 CANADA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 150 CANADA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 151 CANADA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 152 CANADA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 153 CANADA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 154 CANADA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 155 CANADA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 156 CANADA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 157 CANADA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 158 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 159 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 160 CANADA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161 CANADA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 162 CANADA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163 CANADA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164 CANADA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165 CANADA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 166 CANADA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 167 CANADA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 168 CANADA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 169 CANADA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 170 CANADA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 171 CANADA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 172 CANADA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173 CANADA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174 MEXICO OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 175 MEXICO DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 176 MEXICO SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177 MEXICO OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 178 MEXICO VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 179 MEXICO REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 180 MEXICO GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 181 MEXICO DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 182 MEXICO OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 183 MEXICO OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 184 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 185 MEXICO ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 186 MEXICO ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 187 MEXICO PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 188 MEXICO BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 189 MEXICO ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 190 MEXICO MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 191 MEXICO ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 192 MEXICO OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 193 MEXICO VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 194 MEXICO CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 195 MEXICO OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 196 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 197 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 198 MEXICO DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 199 MEXICO TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200 MEXICO LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201 MEXICO INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202 MEXICO ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203 MEXICO OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 204 MEXICO REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 205 MEXICO VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 206 MEXICO INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 207 MEXICO ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 208 MEXICO VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 209 MEXICO OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 210 MEXICO OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211 MEXICO RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA OPHTHALMOLOGY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA OPHTHALMOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA OPHTHALMOLOGY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA OPHTHALMOLOGY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA OPHTHALMOLOGY MARKET: SEGMENTATION
FIGURE 11 THREE SEGMENTS COMPRISE THE NORTH AMERICA OPHTHALMOLOGY MARKET, BY PRODUCTS
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE NORTH AMERICA OPHTHALMOLOGY MARKET FROM 2025 TO 2032
FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA OPHTHALMOLOGY MARKET IN 2025 AND 2032
FIGURE 16 DROC ANALYSIS
FIGURE 17 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024
FIGURE 18 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)
FIGURE 19 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)
FIGURE 20 NORTH AMERICA OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 21 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, 2024
FIGURE 22 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)
FIGURE 23 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)
FIGURE 24 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE
FIGURE 25 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024
FIGURE 26 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)
FIGURE 27 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)
FIGURE 28 NORTH AMERICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE
FIGURE 29 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, 2024
FIGURE 30 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)
FIGURE 31 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)
FIGURE 32 NORTH AMERICA OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024
FIGURE 34 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
FIGURE 35 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 36 NORTH AMERICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 37 NORTH AMERICA OPHTHALMOLOGY MARKET SNAPSHOT
FIGURE 38 NORTH AMERICA OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
